跳至主要内容
临床试验/NCT02563535
NCT02563535已完成4 期

Evaluation of the Use of ACOTEC Drug-Eluting Balloon Litos ® in Below-The-Knee Arteries to Treat Critical Limb Ischemia

Ospedale San Donato2 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
105
试验地点
2
主要终点
Late Lumen Loss (LLL) in the target lesion documented by angiography

研究概览

简要总结

The aim of this study is to evaluate the potential advantage in terms of late lumen loss reduction of Litos drug-eluting balloon vs standard percutaneous transluminal angioplasty in the treatment of below-the-knee disease in patients with critical limb ischemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age>18 years
  • critical limb ischemia (Rutherford class 4-6)
  • angiographic stenosis>50% or occlusion of at least one tibial vessel of at least 40mm for which an interventional treatment is scheduled

排除标准

  • need for major amputation known before intervention
  • allergy to Paclitaxel
  • contraindication for combined antiplatelet treatment
  • life expectancy <1 year
  • hypersensitivity or contraindication to one of the study drugs
  • lack of consent

结局指标

主要结局

Late Lumen Loss (LLL) in the target lesion documented by angiography

时间窗: 6 months

Late Lumen Loss (LLL) in the target lesion documented by angiography

次要结局

  • Number of events of angiographic occlusive restenosis(6 months)
  • Number of events of target lesion revascularization (TLR)(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Leonardo Bolognese, MD

MD

Ospedale San Donato

研究点 (2)

Loading locations...

相似试验